Tim Frandsen

Tim Frandsen has a vast work experience spanning multiple healthcare companies and roles. Tim has served as the Head of Market Development at GT Medical Technologies, where they conduct customer research and analyzes hospital economics for a brain cancer treatment product. Tim has also worked as a Consultant at Synthpop - Healthcare AI, focusing on the application of AI in healthcare and tailoring solutions for healthcare providers. Tim was an Interim CEO at a medical technology company, leading business strategy and guiding product development. Additionally, Tim has held positions such as Senior Director at ZOLL Itamar, Vice President of Business Development at Resonea Inc., and Senior Director at Siemens Healthineers, where they managed global product portfolios and executed cross-functional initiatives. Tim also worked as the Director of Medical Affairs at Abbott and the Vice President of Business Development at TeraRecon Inc. Tim's earlier experience includes a senior role at Smith & Nephew and a director position at TeraRecon Inc. Overall, Tim Frandsen brings extensive knowledge and expertise in strategic planning, commercialization, and product development in the healthcare industry.

Tim Frandsen has a Master of Business Administration (MBA) degree in Management/Business Administration from the University of California, Irvine - The Paul Merage School of Business, which they obtained from 2001 to 2003. Prior to that, they earned a Master's degree in Advanced/Graduate Dentistry and Oral Sciences from The Ohio State University between 1993 and 1997. Tim also holds a Bachelor of Science (BS) degree in Human Biology from the University of Utah, which they completed from 1989 to 1993. Additionally, they have participated in various company-sponsored courses and seminars between 2008 and 2011.